BioSpace: MyMD Pharma Develops Low-Toxicity, Plant-Based TNF-α Regulator

June 1, 2021

BioSpace sat in on MyMD’s recent conference call and caught up with Chief Scientific Officer Adam Kaplin, M.D., Ph.D., shortly afterward to discuss MYMD-1® and its role in treating disease.

View More

Back to All News

Subscribe to receive MyMD announcements
  • This field is for validation purposes and should be left unchanged.